AI
Also, Max Life in India has developed an analytics solution that detects inaccurate medical reports in real time.
Its mobile app is slated to be released in late 2023.
Also, Point Robotics from Taiwan has received a US FDA 510(k) clearance for its surgical robot system.
Also, a new research centre at the University of Melbourne will use AI to advance breast cancer screening.
The technology uses heart rate variability measurements to assess the severity of sepsis in ED patients.
The solution screens for plus disease, which is associated with severe ROP.
Individuals are also less likely to trust AI-suggested interventions than those recommended by humans.
Also, Lunit has received Taiwan's approval for its AI mammography solution.
The AI model still has a modest prediction accuracy and is slated for a wider clinical trial soon.
It will use its fresh funds to complete a multi-site validation study across eight Asia-Pacific markets.